Arcutis Biotherapeutics, Inc. ARQT Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s common stock?
- Arcutis Biotherapeutics, Inc. (ARQT) reported common stock of 300M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s common stock changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s common stock decreased by 0.0% year-over-year, from 300M to 300M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s common stock?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s common stock has grown at a 0.0% compound annual growth rate (CAGR), from 300M to 300M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).